Peter Graham

Chief Legal Officer at ADC Therapeutics

Mr. Graham serves as Chief Legal Officer and has over 25 years of legal, compliance, and executive management experience in publicly and privately held pharmaceutical and medical device companies.

Most recently, from 2015 until its sale to Halozyme Therapeutics, Inc. in 2022, Mr. Graham served as Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary for Antares Pharma, Inc., a commercial-stage specialty pharmaceutical and combination product company. Prior to Antares, Mr. Graham served as Executive Vice President, General Counsel, Chief Compliance Officer, and Global Human Resources for Delcath Systems, Inc., an interventional oncology company focused on liver cancers. Earlier in his career, Mr. Graham served in various senior legal and executive leadership positions at ACIST Medical Systems, Inc., a subsidiary of Bracco, SpA, E-Z-EM, Inc., and AngioDynamics, Inc.

Mr. Graham earned his JD at Yeshiva University’s Benjamin N. Cardozo School of Law and his BA in Political Science at the University of Wisconsin-Madison.

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


ADC Therapeutics

2 followers

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.


Industries

Employees

201-500

Links